BerGenBio ASA (OSL:BGBIO)
Norway · Delayed Price · Currency is NOK 1.168
+0.008 (0.69%)
At close: Oct 23, 2025
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 45.18 million as of October 24, 2025. Its market cap has decreased by -89.59% in one year.
Market Cap
45.18M
Enterprise Value
-24.33M
Revenue
5.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.17
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 1.24B to 45.18M, a decrease of -96.37%. That is a compound annual growth rate of -32.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 45.65M | -85.72% |
| Dec 30, 2024 | 319.77M | -57.22% |
| Dec 29, 2023 | 747.46M | 12.86% |
| Dec 30, 2022 | 662.29M | -63.08% |
| Dec 30, 2021 | 1.79B | -36.16% |
| Dec 30, 2020 | 2.81B | 88.93% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.40B |
| Nordhealth AS | 2.83B |
| ArcticZymes Technologies ASA | 1.53B |
| Photocure ASA | 1.40B |
| Thor Medical ASA | 1.23B |
| Omda AS | 972.06M |
| Vistin Pharma ASA | 962.28M |
| Gentian Diagnostics ASA | 848.23M |